Answers are grounded in this paper and cite their sources.
Come together! A selective Fe-catalysed enantioselective reduction of quinoxalines and benzoxazines with hydrogen is demonstrated. Key to success is the combination of a chiral Brønsted acid and a well-defined non-chiral Fe hydrogenation catalyst. This methodology constitutes an attractive and environmentally favourable alternative to well-established asymmetric hydrogenations by using precious-metal-based catalysts.
No takes yet. Share an insight, caveat, or question.
Fleischer et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: